Cholinergic Nicotinic Receptors and Cognition in PD

计划入组 48 人 · 首次发布于 2014 年 3 月 3 日

Apparent Life Threatening Events, Sudden Infant Death Syndrome and Muscarinic Receptors

计划入组 12 人 · 首次发布于 2017 年 9 月 12 日

Brain Imaging in Depression

计划入组 107 人 · 首次发布于 2002 年 12 月 18 日

cholinergic therapeutics

MDL-203005

ML-007 + muscarinic antagonist

NHI-1

United States

Xi'an No.1 Hospital

China

ALPHA-1 FOUNDATION, INC.

United States

Xanomeline/Trospium (Cobenfy) Approved: A Novel Approach to Schizophrenia Treatment

Schizophrenia Treatment Targeting Cholinergic Receptors Receives FDA Approval

FDA Approves Cobenfy, a Novel Schizophrenia Treatment Targeting Cholinergic Receptors